YAP1/Hippo signaling in bronchial asthma: mechanisms, therapeutic opportunities, and translational challenges
Year: 2026
Type: article
Abstract: Asthma involves variable airflow limitation, chronic airway inflammation and, in some patients, persistent airway-wall remodeling. YAP and TAZ are transcriptional coactivators regulated by Hippo kinases and by actin-dependent mechanical inputs. This review distinguishes observations in human asthma specimens from mechanistic findings in cultured cells and allergen- or chemical-exposure animal models. In human asthma specimens and HDM-exposed mouse lungs, nuclear YAP staining in alveolar type II cells was associated with CTGF production and myofibroblast accumulation. Experimental Treg studies implicate Notch4-associated Hippo and Wnt signaling in impaired suppressive activity and type 17 or type 2 inflammatory responses; airway smooth-muscle experiments connect YAP dephosphorylation and nuclear localization to proliferative and migratory programs. A separate TDI-exposure model implicates mitochondrial ROS, β-catenin destruction-complex stability and YAP1 in epithelial inflammatory responses. These mechanisms differ by cell type and model, and do not establish a common pathway in all asthma phenotypes. Pharmacological studies remain preclinical for asthma; verteporfin and other upstream modulators are not selective probes of YAP/TEAD activity. Future work should test pathway dependence using cell-specific genetic and pharmacological approaches and relate molecular readouts to airway function.
Authors: Yawen Xiao, Jie Wang
Institution: Hainan Medical University
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7233577073
FWCI:
Cites:
Cited by:
Related to:
